rdf:type |
|
lifeskim:mentions |
umls-concept:C0019080,
umls-concept:C0022116,
umls-concept:C0024485,
umls-concept:C0030705,
umls-concept:C0032143,
umls-concept:C0332293,
umls-concept:C0333275,
umls-concept:C0348016,
umls-concept:C0439793,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0520997,
umls-concept:C0751956,
umls-concept:C1292428,
umls-concept:C1510411,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C2603343,
umls-concept:C2926735
|
pubmed:issue |
2
|
pubmed:dateCreated |
2007-1-30
|
pubmed:abstractText |
Intracerebral hemorrhage represents the most feared complication of treatment with intravenous tissue plasminogen activator. We studied whether perfusion-weighted imaging and diffusion-weighted imaging has the potential to identify patients at risk of severe intracerebral hemorrhage after treatment with intravenous tissue plasminogen activator.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1524-4628
|
pubmed:author |
pubmed-author:FiebachJochen BJB,
pubmed-author:FiehlerJensJ,
pubmed-author:KöhrmannMartinM,
pubmed-author:KruetzelmannAnnaA,
pubmed-author:KucinskiThomasT,
pubmed-author:RötherJoachimJ,
pubmed-author:RosenkranzMichaelM,
pubmed-author:SchellingerPeter DPD,
pubmed-author:SobeskyJanJ,
pubmed-author:ThomallaGötzG,
pubmed-author:Zaro WeberOlivierO
|
pubmed:issnType |
Electronic
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
313-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17204683-Adult,
pubmed-meshheading:17204683-Aged,
pubmed-meshheading:17204683-Aged, 80 and over,
pubmed-meshheading:17204683-Brain Ischemia,
pubmed-meshheading:17204683-Cerebral Hemorrhage,
pubmed-meshheading:17204683-Female,
pubmed-meshheading:17204683-Follow-Up Studies,
pubmed-meshheading:17204683-Humans,
pubmed-meshheading:17204683-Infusions, Intravenous,
pubmed-meshheading:17204683-Magnetic Resonance Imaging,
pubmed-meshheading:17204683-Male,
pubmed-meshheading:17204683-Middle Aged,
pubmed-meshheading:17204683-Prospective Studies,
pubmed-meshheading:17204683-Severity of Illness Index,
pubmed-meshheading:17204683-Stroke,
pubmed-meshheading:17204683-Thrombolytic Therapy,
pubmed-meshheading:17204683-Time Factors,
pubmed-meshheading:17204683-Tissue Plasminogen Activator
|
pubmed:year |
2007
|
pubmed:articleTitle |
Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
|
pubmed:affiliation |
Neuro-Zentrum, Klinik und Poliklinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. thomalla@uke.uni-hamburg.de
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|